# Novo Nordisk to invest over 17 billion DKK in Kalundborg manufacturing facilities

Novo Nordisk announced plans to invest more than 17 billion Danish kroner in constructing three new manufacturing facilities and expanding one existing facility at its production site in Kalundborg, Denmark, adding capacity for API, assembly, and packaging.

- Type: Expansion
- Announced: 2021-12-13
- Where: Kalundborg, Denmark, Denmark
- Value: $2.58B (17.0B DKK)
- Jobs: 400
- Starts operating: 2027
- Status: announced
- Products: active pharmaceutical ingredients, oral and injectable products
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Novo Nordisk](https://endata.com/companies/17868.md)

## Sources

- [nordiclifescience.org](https://nordiclifescience.org/novo-nordiskt-to-invest-more-than-17-billion-dkk-in-manufacturing-facilities/), 2021-12-13: "This major investment in our manufacturing facilities in Kalundborg is an important step in building and ensuring future capacity for production of our current and future oral and injectable product portfolio."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.